Jane Street Group, LLC Adaptive Biotechnologies Corp Call Options Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 16, 2021	SELL	$30.02 - $39.87 $4.36 Million - $5.79 Million	-145,300 Reduced 87.42%	20,900 $710,000
Q2 2021 Aug 16, 2021	BUY	$32.22 - $44.59 $173,988 - $240,786	5,400 Added 3.36%	166,200 $6.79 Million
Q1 2021 May 18, 2021	BUY	$37.26 - $67.74 $2.64 Million - $4.8 Million	70,900 Added 78.87%	160,800 $6.47 Million
Q4 2020 Feb 17, 2021	BUY	$45.01 - $65.47 $1.49 Million - $2.16 Million	33,000 Added 58.0%	89,900 $5.32 Million
Q3 2020 Nov 17, 2020	BUY	$35.79 - $48.81 $132,423 - $180,597	3,700 Added 6.95%	56,900 $2.77 Million
Q2 2020 Aug 17, 2020	BUY	$24.95 - $48.38 $1.33 Million - $2.57 Million	53,200 New	53,200 $2.57 Million

219

148M

50.5K

48.2K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $1.19B
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.